Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 2, Episode 13: Finding A Path Forward with Art Krieg
On this episode of The Pharmaverse Podcast, Art Krieg, the President of Zola Therapeutics, tells Michael that vision, endurance, resilience, and a whole lot of grit are needed to run a biotech.
Krieg has faced the rugged terrain and uphill climbs that come with building science-based companies. But just like a marathoner, he’s never stopped putting one foot in front of the other.
๐ง In this episode, Art and Michael discuss:
โ The parallels between biotech leadership and long-distance running
โ Lessons learned from exits, IPOs, and immuno-oncology breakthroughs
โ Why perseverance and pacing are more important than ever in today’s market
๐๐ ๐ฒ๐จ๐ฎ'๐ซ๐ ๐ ๐ฅ๐๐๐๐๐ซ ๐จ๐ซ ๐๐ง ๐๐ฌ๐ฉ๐ข๐ซ๐ข๐ง๐ ๐๐จ๐ฎ๐ง๐๐๐ซ—๐ญ๐ก๐ข๐ฌ ๐ข๐ฌ ๐๐ง ๐๐ฉ๐ข๐ฌ๐จ๐๐ ๐ฒ๐จ๐ฎ ๐๐จ๐ง’๐ญ ๐ฐ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐ข๐ฌ๐ฌ.
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
E.M. Ray, L.A. Carey, K.E. Reeder-Hayes
Leveraging existing data to contextualize phase II clinical trial findings in oncology
Podcast
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Article
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal